Investing.com – U.S. stocks were mixed after the close on Thursday, as gains in the Utilities, Telecoms and Financials sectors led shares higher while losses in the Oil & Gas,...
Investing.com - Agilent Technologies (NYSE:A) reported third quarter earnings that beat analysts' expectations on Wednesday and revenue that topped forecasts. The firm reported...
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art? Indeed, even among the individuals who don't seek to be the ideal market timer, many feel...
It has been about a month since the last earnings report for Agilent Technologies (NYSE:A). Shares have added about 11.5% in that time frame, outperforming the S&P 500. Will...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Buy||Strong Buy||Buy||Buy||Buy|
|Technical Indicators||Strong Buy||Strong Buy||Strong Buy||Strong Buy||Strong Buy|
|Summary||Strong Buy||Strong Buy||Strong Buy||Strong Buy||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Outside Up||1D||Current|
|Doji Star Bearish||1W||Current|
|Three Inside Up||1M||Current|
|Bullish Engulfing||1D||1||Sep 18, 2019|
|Three Inside Up||1W||2||Sep 01, 2019|
|Deliberation Bearish||5H||3||Sep 18, 2019 06:00PM|
|Bank of America||29.90||30.10||29.83||-0.10||-0.33%||29.77M||15:01:56|
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.Read More
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$500||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.